[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

December 2019 | 382 pages | ID: A15EF5920F4EN
GlobalData

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Auto-Immune Diseases Diagnostic Tests - Medical Devices Pipeline Assessment, 2019' provides an overview of Auto-Immune Diseases Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Auto-Immune Diseases Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Auto-Immune Diseases Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Auto-Immune Diseases Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Auto-Immune Diseases Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Auto-Immune Diseases Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Auto-Immune Diseases - Pipeline Products by Stage of Development
3.2 Auto-Immune Diseases - Pipeline Products by Territory
3.3 Auto-Immune Diseases - Pipeline Products by Regulatory Path
3.4 Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
3.5 Auto-Immune Diseases - Ongoing Clinical Trials

4 AUTO-IMMUNE DISEASES - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
4.2 Auto-Immune Diseases - Pipeline Products by Stage of Development

5 AUTO-IMMUNE DISEASES COMPANIES AND PRODUCT OVERVIEW

6 AUTO-IMMUNE DISEASES- RECENT DEVELOPMENTS

7 APPENDIX

LIST OF TABLES

Table 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
Table 2: Auto-Immune Diseases - Pipeline Products by Territory
Table 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
Table 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
Table 5: Auto-Immune Diseases - Ongoing Clinical Trials
Table 6: Auto-Immune Diseases Companies - Pipeline Products by Stage of Development
Table 7: Auto-Immune Diseases - Pipeline Products by Stage of Development
Table 8: Aarhus University Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Biomarker Test - Multiple Sclerosis - Product Status
Table 10: Biomarker Test - Multiple Sclerosis - Product Description
Table 11: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Non-Invasive Diagnostic Test - Celiac Disease - Product Status
Table 13: Non-Invasive Diagnostic Test - Celiac Disease - Product Description
Table 14: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Biomarker Based Assay - Systemic Sclerosis - Product Status
Table 16: Biomarker Based Assay - Systemic Sclerosis - Product Description
Table 17: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Status
Table 18: Mitochondrial DNA Based Assay - Autoimmune and Autoinflammatory Diseases - Product Description
Table 19: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 20: AIMS System - Cardiolipin IgG Test - Product Status
Table 21: AIMS System - Cardiolipin IgG Test - Product Description
Table 22: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Status
Table 23: AtheNA Multi-Lyte System - Cardiolipin IgG Test - Product Description
Table 24: Amarantus Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Diagnostic Assay - Neuromyelitis Optica - Product Status
Table 26: Diagnostic Assay - Neuromyelitis Optica - Product Description
Table 27: Diagnostic Assay - Paraneoplastic Disease - Product Status
Table 28: Diagnostic Assay - Paraneoplastic Disease - Product Description
Table 29: apDia nv Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Diagnostic Test - MS (Multiple Sclerosis) - Product Status
Table 31: Diagnostic Test - MS (Multiple Sclerosis) - Product Description
Table 32: Autoimmune Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Anti-Squalene Antibody Assay - Product Status
Table 34: Anti-Squalene Antibody Assay - Product Description
Table 35: Autoimmune Disease Virus Assay - Graves' Disease - Product Status
Table 36: Autoimmune Disease Virus Assay - Graves' Disease - Product Description
Table 37: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Status
Table 38: Autoimmune Disease Virus Assay - Juvenile Rheumatoid Arthritis - Product Description
Table 39: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Status
Table 40: Autoimmune Disease Virus Assay - Sjogren Syndrome - Product Description
Table 41: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Status
Table 42: Autoimmune Disease Virus Assay - Systemic Lupus Erythematosus - Product Description
Table 43: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Status
Table 45: SYNCHRON LXi 725 Anti-dsDNA Assay - Product Description
Table 46: BG Medicine Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Diagnostic Assay - Multiple Sclerosis - Product Status
Table 48: Diagnostic Assay - Multiple Sclerosis - Product Description
Table 49: Biogen Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Companion Diagnostic Test - Sjogren's Syndrome - Product Status
Table 51: Companion Diagnostic Test - Sjogren's Syndrome - Product Description
Table 52: Biomedal SL Pipeline Products & Ongoing Clinical Trials Overview
Table 53: ELISA DELIAC GFD - Product Status
Table 54: ELISA DELIAC GFD - Product Description
Table 55: IVYLISA DGP8 - Product Status

LIST OF FIGURES

Figure 1: Auto-Immune Diseases - Pipeline Products by Stage of Development
Figure 2: Auto-Immune Diseases - Pipeline Products by Territory
Figure 3: Auto-Immune Diseases - Pipeline Products by Regulatory Path
Figure 4: Auto-Immune Diseases - Pipeline Products by Estimated Approval Date
Figure 5: Auto-Immune Diseases - Ongoing Clinical Trials

COMPANIES MENTIONED

Aarhus University
Adaptive Biotechnologies Corp
Albert Ludwigs University of Freiburg
Alere Inc
Amarantus Diagnostics Inc
apDia nv
Autoimmune Technologies LLC
Beckman Coulter Inc
BG Medicine Inc
Biogen Inc
Biomedal SL
Bionure Farma SL
CDI Laboratories Inc
Charite University Hospital of Berlin
Chronix Biomedical Inc
Cincinnati Children's Hospital Medical Center
Crescendo Bioscience Inc
Digna Biotech SL
DNAlytics SA
Enterome Bioscience SA
Exodus Biosciences LLC
Ezose Sciences Inc.
Flamentera AG
Genalyte Inc
GeNeuro SA
Grifols SA
Hannover Medical School
HealthTell Inc
Helmholtz Centre for Infection Research
HOB Biotech Group Suzhou Co Ltd
Hospital for Special Surgery
Hycor Biomedical Inc
Ignyta Inc (Inactive)
Immunarray Pvt Ltd
Immunodiagnostic Systems Holdings plc
Immunovia AB
ImmusanT Inc
Innobiochips
Inova Diagnostics Inc
IPDx Immunoprofiling Diagnostics GmbH
Iron Horse Diagnostics, Inc.
Johns Hopkins University
Lankenau Institute for Medical Research
LineaGen Inc
Lophius Biosciences GmbH
Louisville Bioscience, Inc.
Max Delbruck Center for Molecular Medicine
Mayo Clinic US
Medica Corp
Merck Millipore Corp
Metabiomics Corporation
Metabolomic Technologies Inc
Metanomics Health GmbH
MSDx Inc
Myriad Genetics Inc
Nanosphere Inc
Neuro Vigor LLC
Northwestern University
NoToPharm srl
Numares AG
OmniBiome Therapeutics Inc
One Way Liver SL
OPKO Health Inc
Op-T-Mune Inc
Oxford Gene Technology Ltd
Oxford Immunotec Ltd
Pediatric Bioscience LLC
Penn State College of Medicine
Phadia AB
ProciseDx LLC
Progentec Diagnostics Inc
Protagen AG
ProteinLogic Ltd
Quanterix Corp
Rambam Health Care Campus
Rappaport Family Institute for Research in the Medical Science
Regulus Therapeutics Inc
Roche Diagnostics International Ltd
Seattle Children's Hospital
Sengenics International Pte Ltd
Sequenom Inc
Shuwen Biotech Co Ltd
SomaLogic Inc
Southern Illinois University Carbondale
SQI Diagnostics Inc
Statens Serum Institut
TBG Diagnostics Ltd
The University of Manchester
The Walter and Eliza Hall Institute of Medical Research
Thermo Fisher Scientific Inc
Toscana Biomarkers Srl
University Health Network
University of Alberta
University of California San Francisco
University of Chicago
University of Colorado
University of Houston
University of Illinois at Chicago
University of Maryland Baltimore
University of Missouri
University of Oxford
University of Pecs
University of Southern California
University Rovira i Virgili
US Biomarkers Inc
Washington University in St Louis
XEPTAGEN SpA
Yale University


More Publications